Congress Proposes New X-Labs Program to Provide $50 Million Yearly for Breakthrough Medical Research
This bill is currently sitting in the House Committee on Energy and Commerce. No action has been taken on the proposal since December 2025, which means it has been stalled for about six months. The committee must review the bill before it can move forward, but most bills like this never receive a vote.
No action since December 2025
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
For-profit entities with nonprofit research subsidiaries are explicitly listed as eligible for X-Labs awards. Small biotech companies or research firms structured this way could receive substantial long-term funding ($5M–$50M/year for 7 years) to pursue breakthrough biomedical research. However, the requirement to forgo other federal research grants during the award period could be a significant trade-off for small businesses that rely on multiple federal funding streams.
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Launching X–Labs for Breakthrough Science Act
Analysis generated by AI. Always verify with official sources.